With the patents of all major monoclonal antibodies set to expire during 2015 - 2020, Biosimilar (or Follow-on) Monoclonal Antibodies are expected to represent the next big thing for generic manufacturers.
With the 7 new products brought in, the Company will obtain more reputation from the public, and be more popular with people who ask for healthcare products.
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the appointment of Mike Reed as Vice President.
A new report by visiongain, a London-based business information company, predicts that world revenues for epigenetic therapies and technologies will reach $2.73bn in 2015.
Life technologies brings about a revolution in the global research community with the launch of its new product, ION Torrent Genome Machine. The product has drastically reduced the time taken for DNA sequencing and thus helped the researchers across the globe.
The Drug Enforcement Administration (DEA) has scheduled National Prescription Drug Take-Back Day for people to properly dispose of unwanted and unused prescription drugs.
CMDBioscience announced today that they were named a "2011 company to watch" for the Cantor Colburn/ CCAT Innovation and Entrepreneurship Summit. The selection was from more than 100 start up and emerging companies that applied to present at the event which will take place on October 27th in New Haven, CT.
ResearchInChina, the vertical portal for Chinese business intelligence, announces the release of a new report -China Animal Vaccine Industry Report, 2010-2011.
Visiongain predicts that the global neuromodulation devices market will be worth $11.61bn by 2021. The market generated sales of $2.70bn in 2010, according to Neuromodulation Devices: World Market Prospects 2011-2021, published in October 2011.
A new report by visiongain, a London-based business information company, predicts that worldwide pharma contract sales revenues will reach $5.24bn in 2015. In particular, non-personal promotional services will stimulate market growth.
Visiongain's latest defence report, The Airborne ISR Market 2011-2021, finds a sector that must cope in an era of defence spending cuts but which is also expected to see robust demand as it is deemed essential to military operations.
SCMS Institute of Biotechnology and Biosciences (SIBB) has entered into a technical collaboration agreement with ubio Biotechnology Systems Pvt. Ltd. for development and commercialization of medical diagnostics.
UBIFRANCE, the French Trade Commission in London, will be hosting a stand at the Pharmacy Show 2011, which will take place at the National Exhibition Centre (NEC), Birmingham (in England), from 9 to 10 October. UBIFRANCE will accompany five French companies at the event and will be situated on stand H110.
Senior management team strengthened as Former Symphony Services executive brings his operations and technology experience and expertise to new leadership role.
Netscribes (India) Pvt. Ltd., launches a report on the Cardiovascular Pharmaceuticals Market in India 2011 as part of Netscribes' Healthcare Industry report series.
High purity tubing manufacturer AdvantaPure will exhibit at five trade shows this fall to showcase its single use systems and components for the pharmaceutical, biopharmaceutical and bioprocess industries. Shows include Interphex Puerto Rico and the ISPE Annual Meeting where AdvantaPure will have product solutions on hand for fluid processing applications.
Visiongain predicts that the market for Parkinson's disease drugs will reach $3754m in 2015. This decade, new products, including adenosine receptor antagonists, will benefit the Parkinson's treatment market and stimulate growth of overall revenue.
Mettler-Toledo India announces the publication of white paper on continuous Real-Time TOC measurements & TOC analyzer. Developed independently by METTLER TOLEDO THORNTON , the white paper takes an in-depth into the various aspects of process analytical technology, continuous measurements, real-time recovery and error to control total organic carbon improving water system performance.
Strategies for Successful & Compliant Medical Communication & Publication Planning within the Pharmaceutical Industry through the Use of Social Media, Teamwork between Departments & Global Communication.
The aluminium industry is emerging as one of the strongest markets after recession as the commodity is gradually gaining prominence in the recovering transportation and construction industries.
A new report by Visiongain predicts that overall revenues for monoclonal antibody (mAb) therapies will rise between 2011 and 2021. The world mAb drugs market will reach $62.3bn in 2015, up from revenues of $44.6bn (USD) in 2010.
During 2010-2011, the biofuels market gained increased interest as the price of oil increased rapidly. Many developed countries, such as the US and countries in the European Union, reconsidered their energy policy.
Visiongain predicts the global market for interventional cardiology devices to be worth $25.5bn by 2021. The market generated $9.8bn in 2010 according to Interventional Cardiology Devices: World Market Prospects 2011-2021, published in September.
Visiongain predicts that world revenues for rheumatoid arthritis drugs will rise strongly between 2011 and 2021. This market will grow to reach $17.3bn in 2015. The rheumatoid arthritis drugs market generated $12.7bn in 2010.
A new report by visiongain, a London-based business information company, predicts that global pharmacovigilance spending will be worth $15.46bn by 2015. The market was worth just under $12bn in 2010.
A new report by visiongain predicts that the global companion diagnostics market will be worth $3.45bn by 2015. The market generated sales of $1.30bn in 2010, according to Companion Diagnostics: World Market Outlook 2011-2021, published in August.
Satisfied Users & 
Approved Press Releases
